NEW YORK, June 27 (Reuters) - Two widely used diabetes medicines, Januvia and Byetta, pose no additional risk for cases of inflamed pancreas compared with other diabetes drugs, according to an ...

BOSTON (Reuters) - Eli Lilly and Co and Amylin Pharmaceuticals Inc said on Tuesday that a trial of their diabetes drug Byetta, which was recently linked with six deaths from pancreatitis, reduced ...

Resource4thePeople announced today that it providing consumers who are following the progress of lawsuits alleging that a class of diabetes medications including Januvia, Janumet, Byetta and Victoza ...

The FINANCIAL — Merck, known as MSD outside the United States and Canada, on June 8 announced the primary results of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS), a ...

If you have had pancreatitis inflammation of the pancreas, it is not known if you have a higher chance of getting it while taking JANUVIA. Before you start taking JANUVIA, tell your doctor if you have ...

The Food and Drug Administration warned Thursday that diabetes drugs might be elevating the rate of pancreatic cancer. Investors shouldn't be surprised. Nor particularly worried. We've known for years ...

Merck, known as MSD outside the United States and Canada, announced the primary results of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS), a placebo-controlled study of the ...